CVS Health is slashing its headcount by 2,900, or 1% of its total workforce. The layoffs will largely focus on corporate positions, a spokesperson said.
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
CVS Health (CVS) reportedly is considering a breakup of its retail pharmacies and Aetna health insurance unit amid struggling results and pressure from investors, according to Reuters and The Wall Street Journal.
Pharmacy chain CVS is exploring options to separate its retail and insurance businesses, reports say.
CVS is conducting a strategic review of options including a possible breakup, as the company faces headwinds from its drugstore chain and Aetna health insurance arm, according to a person familiar with the matter. Dasha Afanasieva reports on Bloomberg Television.
CVS Health Corp (NYSE:CVS) is exploring options to split its retail and insurance divisions in response to investor pressure, according to a Reuters exclusive. The potential separation, which may lead to two publicly traded entities, would reverse CVS's $70 billion acquisition of Aetna.
CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter. The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take.
Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny, with hedge fund Glenview Capital pushing for strategic changes, potentially including management overhaul, and requesting meetings with senior management. Despite current struggles, CVS's long-term potential remains, hinging on improving Medicare Advantage margins and avoiding further downgrades.
“Sell at former peaks” is an old Wall Street expression. People say this because stocks tend to run into resistance when they rally to a price level that has been a peak.
CVS Health is reportedly meeting with a top investor on ways to enhance its business. The pharmacy/healthcare chain was set to meet Monday (Sept.